Price $131.39 |
Market Cap
355.28B
|
Sector Health Care |
Div. Growth
6.20%
|
|
P/E
22.2
|
P/B
4.9
|
P/S
4.86
|
Dividend %
2.60%
|
|
P/CF
-
|
P/FCF
41.0
|
Op. Cash Flow
20.7M
|
FCF
3.2
|
|
Op. Margin
27.50%
|
Net Margin
22.50%
|
ROE
22.90%
|
ROI
17.00%
|
|
ROA
11.30%
|
EPS Growth
10.60%
|
Current Ratio
2.5
|
Debt/Equity
31.90%
|
| Company | Price | P/E | Div. Yield | Market Cap ($Mil) | Rating |
|---|---|---|---|---|---|
| Champions Oncology Inc (CSBR) | $3.75 | - | - | 33.3M | Strong Buy |
| Envision Healthcare Corp (EVHC) | $44.69 | - | - | 6.33B | Strong Buy |
| Misonix, Inc. (MSON) | $10.20 | - | - | 91.7M | Strong Buy |
| Aviragen Therapeutics Inc (AVIR) | $0.65 | - | - | 24.3M | Strong Buy |
| Senomyx Inc. (SNMX) | $0.67 | - | - | 28.8M | Strong Buy |
Please note that all recommendations are based on our model's results and do not represent our personal opinion. The stock Rating process is purely mechanical.
All analysis relies on publicly available financial information. Learn More
